Mphasis

As of 2026-11-06, MPHASIS (₹2,520) exhibits a mixed technical profile characterized by strong daily momentum but conflicting longer-term signals. The daily trend is established and bullish, with the price trading above all key moving averages and the Supertrend indicator, supported by an ADX of 30.11. However, the monthly timeframe remains bearish, with the price below the Supertrend despite being above moving averages, and a Doji pattern forming on the monthly chart suggests indecision at higher levels. Participation was extreme on 2026-11-06, with volume 6.3 times the average and a +7.6% intraday range, yet the close (+0.4%) failed to sustain significant gains, indicating selling pressure near resistance. Key resistance lies immediately at ₹2,523 (high), followed by ₹2,552 and ₹2,576. Support is anchored at the pivot level of ₹2,503, with deeper support at ₹2,461. The stock is currently in the upper-middle of its 50-day range (+66.3%) but near the middle of its 252-day range (+52.7%). Annualized volatility stands at +31.5%, and the current drawdown is -16.3%. A daily close above ₹2,552 would confirm short-term strength, while a break below ₹2,503 could invalidate the daily bullish structure.

Mphasis reported a 3.3% quarter-on-quarter increase in constant-currency revenue for Q2, marking its highest sequential growth in several years and prompting an approximately 8% rise in share price on November 6, 2026. Management projects full-year FY27 revenue growth at the upper end of guidance, citing strong execution and a record-high, predominantly AI-led deal pipeline. Concurrently, Mphasis secured a £35.4 million contract from the Scottish government to administer welfare benefits, a move defended by the company as compliant with procurement guidelines prioritizing value and technical expertise despite political criticism. However, financial flexibility concerns have emerged; Blackstone’s dividend haul from Mphasis is nearing Rs 3,270 crore while operating cash flow has declined by approximately 43 percent over two financial years. Market experts note this divergence requires balancing shareholder returns with aggressive investment needs amid technological disruption. Mirae Asset Sharekhan analyst Muthuselvaraj M provided technical trading outlooks for the stock on November 2, 2026, noting broader market influences.

Mphasis reported Q2 FY27 results on November 5, 2026, triggering an approximately 8% rise in its NSE share price. The company posted a 3.3% quarter-on-quarter increase in constant-currency revenue, marking its highest sequential growth in several years. Management projects full-year FY27 revenue growth to land at the upper end of its guidance range, driven by strong execution and a record-high, predominantly AI-led deal pipeline.

Corporate developments include Mphasis Corporation’s additional USD 4 million investment for a further 4% stake in Aokah Inc., bringing total holdings to 30%. The acquisition of TAP (Theory and Practice Business Intelligence Inc.) for CAD 2.66 million was completed on April 21, 2026, though it is followed by a Canada Revenue Agency demand notice for CAD 6.60 million related to GST/HST. Additionally, the Red Oak Tech customer contract acquisition (up to USD 28 million) had not been consummated as of the board approval date.

Mphasis Limited’s Board approved Q2 FY27 financial results on November 5, 2026, reporting direct revenue growth of 11.3% year-over-year in constant currency. The company secured $466 million in Total Contract Value (TCV) wins for the quarter, with 66% driven by AI-led initiatives, bringing the trailing twelve-month TCV to $1.8 billion. Management provided FY27 guidance for low double-digit revenue growth and stable operating margins between 14.75% and 15.75%, alongside a normalized Days Sales Outstanding (DSO) of 105 days.

On the capital allocation front, Mphasis Corporation completed an additional USD 4 million investment for a further 4% stake in Aokah Inc., raising its total holding to 30%. The acquisition of TAP (Theory and Practice Business Intelligence Inc.) for CAD 2.66 million was also finalized on April 21, 2026. However, the Red Oak Tech customer contract acquisition, valued up to USD 28 million including USD 15 million contingent consideration, had not been consummated as of the board approval date. Additionally, the Canada Revenue Agency issued a demand notice for CAD 6.60 million related to GST/HST following the TAP acquisition.

Institutional ownership saw activity from HDFC Mutual Fund and Kotak Mahindra Mutual Fund under Regulation 29 filings in late October. Separately, the company received Science Based Targets initiative (SBTi) validation for its near-term and net-zero emissions reduction targets, aiming for carbon neutrality across facilities by FY 2030.

Mphasis demonstrates a clear acceleration in operating momentum, with revenue from operations rising sequentially to ₹4,581 crore in Q2 FY2026-27 and net profit increasing to ₹561 crore. This recent quarterly strength aligns with the TTM trend of 14% sales growth and 11% profit growth, supported by a robust 19% Return on Equity over the last year. However, earnings quality faces headwinds as cash conversion deteriorated significantly; CFO/EBITDA share dropped from 114% in Mar 2024 to 66% in Mar 2026, driven by a widening Cash Conversion Cycle that extended from 67 to 96 days due to slower debtor collections.

Financial health shows mixed signals. While fixed assets grew to ₹6,435 crore and equity strengthened to ₹10,798 crore, borrowings increased sharply to ₹2,620 crore. Concurrently, liquidity tightened, with cash and investments falling to ₹1,428 crore (₹681 crore cash + ₹747 crore investments) as of Sep 2026. Ownership structure shifted materially, with promoter holding dropping to 30.53% while DIIs increased to 45.86%, indicating a change in institutional control dynamics.

Mphasis presents a conditional upside case anchored by accelerating operational momentum and strong near-term execution, despite broader market headwinds. The company reported a 3.3% quarter-on-quarter increase in constant-currency revenue for Q2, marking its highest sequential growth in several years. Management guidance projects full-year FY27 revenue growth to land at the upper end of its range, supported by record-high deal volumes that are predominantly AI-led. This operational strength is reflected in the stock’s recent performance, which saw an 8% jump following results and a +9.7% return over the past month. Technical indicators on the daily timeframe show a bullish super-trend direction with the Plus DI (27.96) significantly above the Minus DI (10.74), suggesting short-term buying pressure. Additionally, the company secured a £35.4 million contract from the Scottish government, validating its specialized technical capabilities in public-sector welfare platforms. While monthly trends remain bearish and cash flows have declined, the convergence of top-line acceleration, AI-driven pipeline strength, and immediate technical support provides a constructive basis for monitoring further recovery.

Mphasis faces significant operational and financial headwinds that temper the positive sentiment from recent quarterly results. While revenue growth is strong, the company’s operating cash flow has declined by approximately 43 percent over two financial years, creating a divergence with shareholder returns as Blackstone’s dividend haul nears ₹3,270 crore. This dynamic raises concerns about financial flexibility for future AI-led investments amid technological disruption. Market performance reflects this tension; despite an 8% jump on Q2 results, the stock remains down -10.9% year-to-date and -9.2% over the past year, with a current drawdown of -16.3% against a maximum historical drawdown of -32.0%. Technical indicators show conflicting signals: while daily trends are bullish, the monthly and weekly supertrends remain bearish, suggesting underlying structural weakness. Additionally, the company faces reputational risk, evidenced by public criticism in Scotland over the awarding of a £35.4 million welfare contract to its Bengaluru unit, highlighting potential geopolitical or regulatory scrutiny in key markets.